Ferulic acid and its therapeutic potential as a hormetin for age-related diseases

Biogerontology

Volumn 10, Issue 2, 2009, Pages 97-108

  Barone, Eugenio ^a   Calabrese, Vittorio ^b   Mancuso, Cesare ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aging; Ferulic acid; Free radicals; Hemeoxygenase; Neurodegenerative disorders

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CASPASE; CYCLOOXYGENASE 2; FERULIC ACID; FREE RADICAL; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; POLYPHENOL; PROTEIN KINASE B;

ANTIOXIDANT ACTIVITY; BRAN; CARDIOVASCULAR DISEASE; CELL STRESS; CHRONIC DISEASE; CLINICAL RESEARCH; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG METABOLISM; DRUG STRUCTURE; ENZYME REGULATION; GERIATRIC DISORDER; HUMAN; MAIZE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION; VEGETABLE;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COUMARIC ACIDS; DIABETES MELLITUS; FREE RADICAL SCAVENGERS; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; SKIN AGING;

EID: 61849147931     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-008-9160-8     Document Type: Review

References (88)

1. Anselmi C, Centini M, Maggiore M et al (2008) Non-covalent inclusion of ferulic acid with alpha-cyclodextrin improves photo-stability and delivery: NMR and modeling studies. J Pharm Biomed Anal 46:645-652. doi: 10.1016/j.jpba.2007.11.037
2. Barnham KJ, Cappai R, Beyreuther K et al (2006) Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem Sci 31:465-472. doi: 10.1016/j.tibs.2006.06.006
3. Bourne LC, Rice-Evans C (1998) Bioavailability of ferulic acid. Biochem Biophys Res Commun 253:222-277. doi: 10.1006/bbrc.1998.9681
4. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36:1307-1313. doi: 10.1080/1071576021000049890
5. Calabrese V, Guagliano E, Sapienza M et al (2006a) Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem 55:263-282
6. Calabrese V, Sultana R, Scapagnini G et al (2006b) Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal 8:1975-1986. doi: 10.1089/ ars.2006.8.1975
7. Calabrese V, Mancuso C, Calvani M et al (2007a) Nitric oxide in the central nervous system: Neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766-775. doi: 10.1038/nrn2214
8. Calabrese V, Mancuso C, Sapienza M et al (2007b) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299-306. doi: 10.1379/CSC-270.1
9. Calabrese V, Calafato S, Puleo E et al (2008) Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblast: Role of vitagenes. Clin Dermatol (in press)
10. Centers for Disease Control and Prevention (CDC) (2001) Prevalence of healthy lifestyle characteristics - Michigan, 1998 and 2000. MMWR Morb Mortal Wkly Rep 50(35):758-761
11. Cho JY, Kim HS, Kim DH et al (2005) Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Prog Neuropsychopharmacol Biol Psychiatry 29:901-907. doi: 10.1016/ j.pnpbp. 2005.04.022
12. Cione E, Tucci P, Senatore V et al (2008) Synthesized esters of ferulic acid induce release of cytochrome c from rat testes mitochondria. J Bioenerg Biomembr 40:19-26. doi: 10.1007/s10863-007-9097-7
13. Clifford MN (1999) Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 79:362-372. doi:10.1002/ (SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
14. Comporti M (1989) Three models of free radical-induced cell injury. Chem Biol Interact 72:1-56. doi: 10.1016/0009-2797(89)90016-1
15. Couteau D, McCartney AL, Gibson GR et al (2001) Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. J Appl Microbiol 90:873-881. doi: 10.1046/j.1365-2672.2001.01316.x
16. D'Archivio M, Filesi C, Di Benedetto R et al (2007) Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita 43:348-361
17. Edelman SV (1998) Type II diabetes mellitus. Adv Intern Med 43:449-500
18. FitzGerald RJ, Murray BA, Walsh DJ (2004) Hypotensive peptides from milk proteins. J Nutr 134:980S-988S
19. Frances C, Robert L (1984) Elastin and elastic fibers in normal and pathologic skin. Int J Dermatol 23:166-179. doi: 10.1111/ j.1365-4362.1984.tb04506.x
20. Fujita A, Sasaki H, Doi A et al (2008) Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats. Diabetes Res Clin Pract 79:11-17. doi: 10.1016/j.diabres.2007.08.009
21. Giacchetti G, Sechi LA, Rilli S et al (2005) The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 16:120-126. doi: 10.1016/j.tem.2005.02.003
22. Graf E (1992) Antioxidant potential of ferulic acid. Free Radic Biol Med 13:435-448. doi: 10.1016/0891-5849(92)90184-I
23. Hassan HH, Denis M, Krimbou L et al (2006) Cellular cholesterol homeostasis in vascular endothelial cells. Can J Cardiol 22(Suppl B):35B-40B
24. Hinault MP, Ben-Zvi A, Goloubinoff P (2006) Chaperones and proteases: cellular fold-controlling factors of proteins in neurodegenerative diseases and aging. J Mol Neurosci 30:249-265. doi: 10.1385/JMN:30:3:249
25. Hirose M, Takahashi S, Ogawa K et al (1999) Phenolics: Blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem Toxicol 37:985-992. doi: 10.1016/S0278-6915(99)00092-7
26. Hölzle E (1992) Pigmented lesions as a sign of photodamage. Br J Dermatol Suppl 41:48-50
27. Inoguchi T, Sonta T, Tsubouchi H et al (2003) Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: Role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14:S227-S232. doi: 10.1097/01.ASN.0000077407.90309.65
28. Jayaprakasam B, Vanisree M, Zhang Y et al (2006) Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J Agric Food Chem 54:5375-5381. doi: 10.1021/jf060899p
29. Jin Y, Yan EZ, Fan Y et al (2005) Sodium ferulate prevents amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/protein kinase B in rat hippocampus. Acta Pharmacol Sin 26:943-951. doi: 10.1111/j.1745-7254.2005.00158.x
30. Jin Y, Fan Y, Yan EZ et al (2006) Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus. Acta Pharmacol Sin 27:1309-1316. doi: 10.1111/j.1745-7254.2006.00414.x
31. Jung EH, Kim SR, Hwang IK et al (2007) Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J Agric Food Chem 55:9800-9804. doi: 10.1021/jf0714463
32. Kanski J, Aksenova M, Stoyanova A et al (2002) Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem 13:273-281. doi: 10.1016/ S0955-2863(01)00215-7
33. Katsuki H, Nakai S, Hirai Y et al (1990) Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323-326. doi: 10.1016/0014-2999(90)90099-R
34. Khanduja KL, Avti PK, Kumar S et al (2006) Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: A Bcl-2 independent mechanism. Biochim Biophys Acta 1760:283-289
35. King C, Tang W, Ngui J et al (2001) Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61:49-153. doi: 10.1093/ toxsci/61.1.49
36. Kiritoshi S, Nishikawa T, Sonoda K et al (2003) Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy. Diabetes 52:2570-2577. doi: 10.2337/diabetes.52.10.2570
37. Kligman LH (1996) The hairless mouse model for photoaging. Clin Dermatol 14:183-195. doi: 10.1016/0738-081X(95)00154-8
38. Kligman LH, Akin FJ, Kligman AM (1985) The contributions of UVA and UVB to connective tissue damage in hairless mice. J Invest Dermatol 84:272-276. doi: 10.1111/1523-1747.ep12265353
39. Kroon PA, Faulds CB, Ryden P et al (1997) Release of Covalently Bound Ferulic Acid from Fiber in the Human Colon. J Agric Food Chem 45:661-667. doi: 10.1021/jf9604403
40. Kurumbail RG, Kiefer JR, Marnett LJ (2001) Cyclooxygenase enzymes: catalysis and inhibition. Curr Opin Struct Biol 11:752-760. doi: 10.1016/ S0959-440X(01)00277-9
41. Li FQ, Su H, Wang J et al (2008) Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharm 349:274-282. doi: 10.1016/j.ijpharm.2007.08.001
42. Lin FH, Lin JY, Gupta RD et al (2005) Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol 125:826-832. doi: 10.1111/j.0022-202X.2005.23768.x
43. Lin JY, Tournas JA, Burch JA et al (2008) Topical isoflavones provide effective photoprotection to skin. Photodermatol Photoimmunol Photomed 24:61-66. doi: 10.1111/j.1600-0781.2008.00329.x
44. Makrantonaki E, Zouboulis CC (2007) Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci 1119:40-50. doi: 10.1196/ annals.1404.027
45. Mancuso C (2004) Heme oxygenase and its products in the nervous system. Antioxid Redox Signal 6:878-887
46. Mancuso C, Pani G, Calabrese V (2006) Bilirubin: An endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep 11:207-213. doi: 10.1179/135100006X154978
47. Mancuso C, Bates TE, Butterfield DA et al (2007a) Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 16:1921-1931. doi: 10.1517/13543784.16.12.1921
48. Mancuso C, Scapagnini G, Currò D et al (2007b) Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 12:1107-1123. doi: 10.2741/2130
49. Ohsaki AY, Shirakawa H, Koseki T, Komai M (2008) Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 56(8):2825-2830
50. Ou S, Kwok KC (2004) Ferulic acid: Pharmaceutical functions, preparation and applications in food. J Sci Food Agric 84:1261-1269. doi: 10.1002/ jsfa.1873
51. Patrono C, Patrignani P, García Rodríguez LA (2001) Cyclooxygenase-selective inhibition of prostanoid formation: Transducing biochemical selectivity into clinical read-outs. J Clin Invest 108(1):7-13
52. Poquet L, Clifford MN, Williamson G (2008) Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos 36:190-197. doi: 10.1124/dmd.107.017558
53. Preziosi P, Loscalzo B (1957a) Pharmacodynamic research on the active principle of Cynara scolimus(1, 4-dicaffeiylquinic acid): Effect on blood cholesterol values & on triton-induced hypercholesterolemia. Boll Soc Ital Biol Sper 33:679-682
54. Preziosi P, Loscalzo B (1957b) Experimental evaluation of 1, 4-dicaffeiylquinic acid, the active principle of artichoke. Arch Ital Sci Farmacol 7:249-296
55. Preziosi P, Loscalzo B (1958) Pharmacological properties of 1, 4 dicaffeylquinic acid, the active principle of Cynara scolimus. Arch Int Pharmacodyn Ther 117:63-80
56. Preziosi P, Loscalzo B, Bianchi A (1957) Pharmacodynamic research on the active principle of Cynara scolimus (1, 4-dicaffeiylquinic acid): Effect on choleresis. Boll Soc Ital Biol Sper 33:672-674
57. Qin J, Chen D, Hu H (2007) Body distributioin of RGD-mediated liposome in brain-targeting drug delivery. Yakugaku Zasshi 127:1497-1501. doi: 10.1248/yakushi.127.1497
58. Rattan SI (2008a) Hormesis in aging. Ageing Res Rev 7:63-78. doi: 10.1016/j.arr.2007.03.002
59. Rattan SI (2008b) Principles and practice of hormetic treatment of aging and age-related diseases. Hum Exp Toxicol 27:151-154. doi: 10.1177/ 0960327107083409
60. Rechner AR, Pannala AS, Rice-Evans CA (2001a) Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic Res 35:195-202. doi: 10.1080/10715760100300741
61. Rechner AR, Spencer JP, Kuhnle G et al (2001b) Novel biomarkers of the metabolism of caffeic acid derivatives in vivo. Free Radic Biol Med 30:1213-1222. doi: 10.1016/S0891-5849(01)00506-8
62. Riccioni G, Bucciarelli T, Mancini B et al (2007) The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin Investig Drugs 16:25-32. doi: 10.1517/ 13543784.16.1.25
63. Robbie L, Libby P (2001) Inflammation and atherothrombosis. Ann N Y Acad Sci 947:167-179
64. Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186. doi: 10.1016/S0955-0674(97)80061-0
65. Rondini L, Peyrat-Maillard MN, Marsset-Baglieri A et al (2002) Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats. J Agric Food Chem 50:3037-3041. doi: 10.1021/jf011295i
66. Rondini L, Peyrat-Maillard MN, Marsset-Baglieri A et al (2004) Bound ferulic acid from bran is more bioavailable than the free compound in rat. J Agric Food Chem 52:4338-4343. doi: 10.1021/jf0348323
67. Rouzer CA, Marnett LJ (2003) Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Chem Rev 103:2239-2304. doi: 10.1021/cr000068x
68. Saija A, Tomaino A, Trombetta D et al (2000) In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int J Pharm 199:39-47. doi: 10.1016/S0378-5173(00)00358-6
69. Saulnier L, Vigouroux J, Thibault JF (1995) Isolation and partial characterization of feruloylated oligosaccharides from maize bran. Carbohydr Res 272:241-253. doi: 10.1016/0008-6215(95)00053-V
70. Scapagnini G, Butterfield DA, Colombrita C et al (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 6:811-818
71. Silberberg M, Morand C, Mathevon T et al (2006) The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J Nutr 45:88-96. doi: 10.1007/s00394-005-0568-5
72. Souto EB, Anselmi C, Centini M et al (2005) Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN). Int J Pharm 295:261-268. doi: 10.1016/j.ijpharm.2005.02.005
73. Srinivasan M, Rukkumani R, Ram Sudheer A et al (2005) Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity. Fundam Clin Pharmacol 19:491-496. doi: 10.1111/j.1472-8206.2005.00332.x
74. Sudheer AR, Muthukumaran S, Kalpana C et al (2007) Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: A comparison with N-acetylcysteine. Toxicol In Vitro 21:576-585. doi: 10.1016/ j.tiv.2006.11.006
75. Sultana R, Ravagna A, Mohmmad-Abdul H et al (2005) Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Neurochem 92:749-758. doi: 10.1111/j.1471-4159.2004.02899.x
76. Suzuki A, Kagawa D, Fujii A et al (2002) Short- and long-term effects of ferulic acid on blood pressure in spontaneously hypertensive rats. Am J Hypertens 15:351-357. doi: 10.1016/S0895-7061(01)02337-8
77. Suzuki A, Yamamoto M, Jokura H et al (2007) Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats. Am J Hypertens 20:508-513. doi: 10.1016/ j.amjhyper.2006.11.008
78. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252-266
79. van der Logt EM, Roelofs HM, Nagengast FM et al (2003) Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24:1651-1656. doi: 10.1093/carcin/bgg117
80. von Herrath M, Sanda S, Herold K (2007) Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol 7:988-994. doi: 10.1038/ nri2192
81. Wang B, Ouyang J, Liu Y et al (2004) Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol 43:549-554. doi: 10.1097/00005344-200404000-00010
82. Wang X, Martindale JL, Liu Y et al (1998) The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333:291-300
83. Yamagata K, Andreasson KI, Kaufmann WE et al (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11:371-386. doi: 10.1016/ 0896-6273(93)90192-T
84. Yan JJ, Cho JY, Kim HS et al (2001) Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 133:89-96. doi: 10.1038/sj.bjp. 0704047
85. Zhao Z, Egashira Y, Sanada H (2003) Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic acid. J Nutr 133:1355-1361
86. Zhao Z, Egashira Y, Sanada H (2004) Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J Nutr 134:3083-3088
87. Zhou H, Li XM, Meinkoth J et al (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151:483-494. doi: 10.1083/jcb.151.3.483
88. Zhui Y, Jing-Ping OY, Yongming L et al (2000) Experimental study of the antiatherogenesis effect of Chinese medicine angelica and its mechanisms. Clin Hemorheol Microcirc 22:305-310